Overview

Gabapentin for Perioperative Pain Relief in Surgical Abortion

Status:
Completed
Trial end date:
2018-03-30
Target enrollment:
0
Participant gender:
Female
Summary
Gabapentin preoperative use for evaluation of benefit to reduce pain during and after surgical office-based abortion.
Phase:
Early Phase 1
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University of Nevada, Las Vegas
Treatments:
Gabapentin
Criteria
Inclusion Criteria:

- Women seeking surgical abortion between 5 and 23 6/7 weeks of ultrasound age.

- English or Spanish speaking

- eligible for office-based surgical pregnancy termination

Exclusion Criteria:

- present use of gabapentin or pregabalin,

- renal disease

- sensitivity or allergy to gabapentin

- Missed abortion